US2022213173A1PendingUtilityA1
Modified collagen
Est. expiryJan 9, 2032(~5.5 yrs left)· nominal 20-yr term from priority
A61L 2300/23A61L 24/10C08L 89/06C08L 89/00A61L 27/24A61L 2300/406C07K 14/78A61K 31/445A61P 31/04A61K 38/39A61L 2300/402A61L 2300/204A61K 31/7036A61K 47/42C08J 9/28A61L 27/54
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.
Claims
exact text as granted — not AI-modified1 . A method for preparing a modified collagen, the method comprising the steps of:
(a) providing isolated collagen; (b) freezing the isolated collagen; and (c) dehydrating the frozen collagen.
2 . A method according to claim 1 , further comprising the step of (d) maturing the dehydrated collagen.
3 . A method according to claim 1 or 2 , wherein the providing step comprises the step of removing the fluid prior to the providing step to provide a dispersion having a concentration of about 3-30% (w/w) collagen particles.
4 . A method according to any one of claims 1 - 3 , wherein the freezing step comprises freezing to a temperature of about −33° C. to about −42° C.
5 . A method according to any one of claims 1 - 4 , wherein the dehydrating step comprises removing the aqueous phase by reducing the pressure to about 0.05 to about 0.5 mbar.
6 . A method according to any one of claims 1 - 5 , wherein the dehydrating step comprises increasing the temperature of the collagen to about +30° C.
7 . A method according to any one of claims 1 - 6 , wherein the dehydrating step comprises at least one equilibrating step, wherein the or each equilibrating step comprises maintaining the temperature at a constant temperature for at least 10 mins.
8 . A method according to claim 7 , wherein the dehydrating step comprises six equilibrating steps, each equilibrating step being conducted when the temperature is increased by about 10° C.
9 . A method according to claim 2 , wherein the maturing step comprises storing the dehydrated collagen at a temperature of at least 2° C.
10 . A method according to claim 2 or 9 , wherein the maturing step is conducted for a period of at least one week.
11 . A method according to any one of claim 2 , 9 , or 10 , wherein the maturing step comprises storing the dehydrated collagen at a temperature of at least 2° C. for a period of at least six months.
12 . A method according to any one of claim 2 , 9 , or 10 , wherein the maturing step comprises storing the dehydrated collagen at a temperature of at least 30° C. for a period of at least two months.
13 . A method according to any one of claim 2 , 9 , or 10 , wherein the maturing step comprises storing the dehydrated collagen at a temperature of at least 40° C. for a period of at least six weeks.
14 . A method according to any one of claim 2 , 9 , or 10 , wherein the maturing step comprises storing the dehydrated collagen at a temperature of at least 65° C. for a period of at least one week.
15 . A method according to any one of claim 2 or 9 - 14 , wherein the maturing step is conducted at a relative humidity of less than 80%.
16 . A modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen.
17 . A composition comprising a modified collagen according to claim 16 , or a modified collagen prepared according to any one of claims 1 - 15 , for use in treating or preventing surgical adhesions.
18 . A composition for use according to claim 17 , wherein use comprises the administration of the composition at a biological membrane.
19 . A method for the manufacture of a composition comprising a modified collagen according to claim 16 or a modified collagen prepared according to any one of claims 1 - 15 , the method comprising the steps of:
(a) providing the modified collagen;
(b) preparing an aqueous dispersion of the modified collagen;
(c) degrading the aqueous dispersion; and
(d) dehydrating the aqueous dispersion.
20 . A method according to claim 19 , wherein the preparing step comprises adding water heated to about 35 to about 42° C. to the modified collagen, prior to adding to the modified collagen.
21 . A method of preparing a drug delivery composition for sustained drug release, the method comprising the steps of:
(a) providing isolated collagen; (b) freezing the isolated collagen; and (c) dehydrating the frozen collagen.
22 . A method according to claim 21 , further comprising the step of (d) maturing the dehydrated collagen.
23 . A method according to claim 21 or 22 , further comprising the step of providing a drug to which the matured collagen is added, or which is added to the matured collagen.
24 . A method according to claim 23 , wherein the drug is selected from gentamicin ((3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol), or a salt or prodrug thereof, and bupivacaine ((RS)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide), or a salt or prodrug thereof.
25 . A method according to claim 23 or 24 , further comprising the step of lyophilizing and/or dehydrating, the drug-containing drug delivery composition.
26 . A drug delivery composition obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen.Join the waitlist — get patent alerts
Track US2022213173A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.